Skip to main content
xMedica

Search

20 studies match these filters. Showing 1–20 of 20 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07915791A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

This study is for adult participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who continue to experience exacerbations despite standard of care triple therapy treatment. It will assess the effectiveness and safety of two investigational drugs, GSK3862995B and GSK5784283,…

✓ Contact✗ Claimed

Nearest site: Derby, Kansas, United States — 54 km away · 10 sites in total · contact listed

RecruitingPhase 2279target10 / 22026Nov 17, 2026
NCT07780669A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

The study primarily aims to demonstrate the superiority of GSK5784283 as an add-on therapy compared to placebo in reducing the annualized rate of moderate and severe chronic obstructive pulmonary disease (COPD) exacerbations.

✓ Contact✗ Claimed

Nearest site: Derby, Kansas, United States — 54 km away · 11 sites in total · contact listed

RecruitingPhase 3624target11 / 22026Nov 17, 2026
NCT06283966A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 922 sites in total

RecruitingPhase 35,250target922 / 372024Oct 2, 2026
NCT06932263Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 223 sites in total

RecruitingPhase 2540target223 / 212025Oct 30, 2026
NCT05655182A Study of BLB-201 RSV Vaccine in Infants and Children

This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 m…

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 18 sites in total · contact listed

RecruitingPhase 1 / Phase 2137target18 / 12023Oct 21, 2026
NCT06122077Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 36 sites in total · contact listed

Recruiting20,000target36 / 12023Aug 5, 2025
NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will deter…

✓ Contact✗ Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 1,229 sites in total

RecruitingPhase 2 / Phase 310,000target1,229 / 12019May 18, 2026
NCT04613596Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com…

✓ Contact✗ Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 776 sites in total · contact listed

RecruitingPhase 2 / Phase 3626target776 / 472020Nov 19, 2026
NCT04181060Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signa…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 604 sites in total · contact listed

RecruitingPhase 3300target604 / 12020Nov 4, 2026
NCT07213778REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 57 sites in total

RecruitingPhase 32,000target57 / 52025Nov 19, 2026
NCT04267848Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immun…

✓ Contact✗ Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 1,151 sites in total

RecruitingPhase 31,210target1,151 / 22020Nov 12, 2026
NCT06561386A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 330 sites in total · contact listed

RecruitingPhase 31,000target330 / 312024Nov 9, 2026
NCT05624996Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or targeted therapy with osimertinib) versus the usual treatment alone…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 477 sites in total · contact listed

RecruitingPhase 3474target477 / 22023Aug 17, 2026
NCT07293247A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 125 sites in total · contact listed

RecruitingPhase 2164target125 / 12026Nov 3, 2026
NCT07779408Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i…

✓ Contact✗ Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 16 sites in total

RecruitingPhase 1 / Phase 2640target16 / 12026Sep 15, 2026
NCT07159763A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000 deaths per year (WHO 2025). Yearly administration of an influenza vaccine for the prevention of influenza is currently recommended. However, the real-…

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 211 sites in total · contact listed

RecruitingPhase 310,000target211 / 62025Nov 17, 2026
NCT06605404Pan-tumor MRD Study

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, fo…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 47 sites in total · contact listed

Recruiting1,350target47 / 12025Sep 24, 2026
NCT07629440A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco…

✓ Contact✗ Claimed

Nearest site: Derby, Kansas, United States — 54 km away · 134 sites in total

RecruitingPhase 33,230target134 / 32026Nov 18, 2026
NCT07415031A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorect…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 101 sites in total · contact listed

RecruitingPhase 2170target101 / 212026Nov 12, 2026
NCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 751 sites in total · contact listed

Recruiting2,900target751 / 12022Nov 4, 2026

Filters

Clear all filters